Figures computed from official regulatory filings — .
Statistical track record
FreeWin rates and median returns are available with a free account (5 insiders/month).
This page republishes public regulatory disclosures.
| Company | Type | Value · USD | Details | |
|---|---|---|---|---|
Ceres, Inc.Listing unverified | Other | $1.2B | SEC | |
Pyxis Oncology, Inc.Listing on record | Buy | $5M | SEC | |
Pyxis Oncology, Inc.Listing on record | Buy | $5M | SEC | |
BioAtla, Inc.Listing on record | OtherD (derivative) | — | SEC | |
BioAtla, Inc.Listing on record | Other | — | SEC | |
Viatris IncListing on record | Other | — | SEC | |
Viatris IncListing on record | Other | — | SEC | |
Cerevel Therapeutics Holdings, Inc.Listing unverified | Buy | $12M | SEC | |
SpringWorks Therapeutics, Inc.Listing unverified | OtherD (derivative) | — | SEC | |
SpringWorks Therapeutics, Inc.Listing unverified | Buy | $900K | SEC | |
SpringWorks Therapeutics, Inc.Listing unverified | OtherD (derivative) | — | SEC | |
SpringWorks Therapeutics, Inc.Listing unverified | Other | — | SEC | |
SpringWorks Therapeutics, Inc.Listing unverified | Other | — | SEC | |
SpringWorks Therapeutics, Inc.Listing unverified | OtherD (derivative) | — | SEC | |
SpringWorks Therapeutics, Inc.Listing unverified | Other | — | SEC | |
Allogene Therapeutics, Inc.Listing on record | Other | — | SEC | |
Allogene Therapeutics, Inc.Listing on record | Buy | $1M | SEC | |
Allogene Therapeutics, Inc.Listing on record | OtherD (derivative) | — | SEC | |
RHYTHM PHARMACEUTICALS, INC.Listing on record | OtherD (derivative) | — | SEC | |
RHYTHM PHARMACEUTICALS, INC.Listing on record | OtherD (derivative) | — | SEC | |
RHYTHM PHARMACEUTICALS, INC.Listing on record | Other | — | SEC | |
RHYTHM PHARMACEUTICALS, INC.Listing on record | Buy | $680K | SEC | |
RHYTHM PHARMACEUTICALS, INC.Listing on record | Other | — | SEC | |
SYNLOGIC, INC.Listing on record | Other | $1.7M | SEC | |
SYNLOGIC, INC.Listing on record | Buy | $5M | SEC |